Cargando…
Delivering Antisense Oligonucleotides across the Blood‐Brain Barrier by Tumor Cell‐Derived Small Apoptotic Bodies
The blood‐brain barrier (BBB) is the most restrictive and complicated barrier that keeps most biomolecules and drugs from the brain. An efficient brain delivery strategy is urgently needed for the treatment of brain diseases. Based on the studies of brain‐targeting extracellular vesicles (EVs), the...
Autores principales: | Wang, Yulian, Pang, Jiayun, Wang, Qingyun, Yan, Luocheng, Wang, Lintao, Xing, Zhen, Wang, Chunming, Zhang, Junfeng, Dong, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261483/ https://www.ncbi.nlm.nih.gov/pubmed/34258157 http://dx.doi.org/10.1002/advs.202004929 |
Ejemplares similares
-
Antisense oligonucleotides delivered to the amniotic cavity in utero modulate gene expression in the postnatal mouse
por: Depreux, Frederic F., et al.
Publicado: (2016) -
Systemic Brain Delivery of Antisense Oligonucleotides across the Blood–Brain Barrier with a Glucose‐Coated Polymeric Nanocarrier
por: Min, Hyun Su, et al.
Publicado: (2020) -
Antisense oligonucleotides in neurological disorders
por: Wurster, Claudia D., et al.
Publicado: (2018) -
Molecular Mechanisms of Antisense Oligonucleotides
por: Crooke, Stanley T.
Publicado: (2017) -
Antisense oligonucleotides: A primer
por: Scoles, Daniel R., et al.
Publicado: (2019)